Back to all News

Opportunities and challenges for the development of M1 muscarinic receptor positive allosteric modulators in the treatment for neurocognitive deficits

Nguyen HTM, Valant C, van der Westhuizen ET, Langmead CJ, Tobin AB, Sexton PM, Christopoulos A. Opportunities and challenges for the development of M1 muscarinic receptor positive allosteric modulators in the treatment for neurocognitive deficits. Br J Pharmacol 10(4), 2022. https://doi.org/10.1111/bph.15982